This JAMA Network Open study examines the impact of cannabis legalization on high-risk young adults in Ontario, Canada, revealing mixed results. While frequent users reduced their cannabis use post-legalization, leading to fewer adverse consequences, those who were non-users before legalization slightly increased their use over time.
Japan accepts for review GSK’s Nucala application
GSK’s sJNDA for Nucala to treat rhinosinusitis has been accepted for review in Japan. Credit: GSK. The Japanese Ministry of Health, Labour and Welfare (MHLW)